Search Results - Jacob D. Durrant
- Showing 1 - 18 results of 18
-
1
Generative AI in structure-based drug discovery by Zhuoya Zhong, Jacob D. Durrant
Published in BMC Biology (2026-03-01)Get full text
Article -
2
Open-Source Browser-Based Tools for Structure-Based Computer-Aided Drug Discovery by Ann Wang, Jacob D. Durrant
Published in Molecules (2022-07-01)Get full text
Article -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Novel mutation in hexokinase 2 confers resistance to 2-deoxyglucose by altering protein dynamics. by Erich Hellemann, Jennifer L Walker, Mitchell A Lesko, Dakshayini G Chandrashekarappa, Martin C Schmidt, Allyson F O'Donnell, Jacob D Durrant
Published in PLoS Computational Biology (2022-03-01)Get full text
Article -
14
The chaperone PrsA2 regulates the secretion, stability, and folding of listeriolysin O during Listeria monocytogenes infection by Charles Agbavor, Adriana Zimnicka, Allison Kumar, Jada L. George, Madeline Torres, Gerd Prehna, Francis Alonzo, Jacob D. Durrant, Nancy E. Freitag, Laty A. Cahoon
Published in mBio (2024-07-01)Get full text
Article -
15
Genome mining yields putative disease-associated ROMK variants with distinct defects. by Nga H Nguyen, Srikant Sarangi, Erin M McChesney, Shaohu Sheng, Jacob D Durrant, Aidan W Porter, Thomas R Kleyman, Zachary W Pitluk, Jeffrey L Brodsky
Published in PLoS Genetics (2023-11-01)Get full text
Article -
16
Changing course: Glucose starvation drives nuclear accumulation of Hexokinase 2 in S. cerevisiae. by Mitchell A Lesko, Dakshayini G Chandrashekarappa, Eric M Jordahl, Katherine G Oppenheimer, Ray W Bowman, Chaowei Shang, Jacob D Durrant, Martin C Schmidt, Allyson F O'Donnell
Published in PLoS Genetics (2023-05-01)Get full text
Article -
17
A multidimensional strategy to detect polypharmacological targets in the absence of structural and sequence homology. by Jacob D Durrant, Rommie E Amaro, Lei Xie, Michael D Urbaniak, Michael A J Ferguson, Antti Haapalainen, Zhijun Chen, Anne Marie Di Guilmi, Frank Wunder, Philip E Bourne, J Andrew McCammon
Published in PLoS Computational Biology (2010-01-01)Get full text
Article -
18
Comparative chemical genomics reveal that the spiroindolone antimalarial KAE609 (Cipargamin) is a P-type ATPase inhibitor by Gregory M. Goldgof, Jacob D. Durrant, Sabine Ottilie, Edgar Vigil, Kenneth E. Allen, Felicia Gunawan, Maxim Kostylev, Kiersten A. Henderson, Jennifer Yang, Jake Schenken, Gregory M. LaMonte, Micah J. Manary, Ayako Murao, Marie Nachon, Rebecca Murray, Maximo Prescott, Case W. McNamara, Carolyn W. Slayman, Rommie E. Amaro, Yo Suzuki, Elizabeth A. Winzeler
Published in Scientific Reports (2016-06-01)Get full text
Article
